Here's why Eli Lilly is down heading into earnings — and how we plan to play it

  • 📰 CNBC
  • ⏱ Reading Time:
  • 22 sec. here
  • 18 min. at publisher
  • 📊 Quality Score:
  • News: 68%
  • Publisher: 72%

Stock Markets News

Earnings,Technology,Breaking News: Technology

The Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. U.S. stocks advanced Wednesday after breaking the market's three-day losing streak in the previous session. The S & P 500 climbed 1.5%, while the Dow Jones Industrial Average and Nasdaq Composite jumped 1% and 1.9%, respectively. "What we have here today is a good day," Jim Cramer said.

Still, Jim said Eli Lilly shares could fall further after the drugmaker releases its own quarterly results on Thursday. "That's not the end of the world. If it really comes down hard, we will be tempted to buy some," he added. "There's a lot to like about Eli Lilly." 3. Amazon received upbeat news regarding its e-commerce business after CVS Health's quarterly earnings on Wednesday.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines